Clinical trial

A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis

NCT00499551 · Asociación para Evitar la Ceguera en México, Other · Withdrawn

Key facts

NCT number NCT00499551
Title A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Official title A Phase I/IIa Study of the Treatment of None-infectious Anterior, Intermediate, Posterior and Panuveitis, With the Use of Dexamethasone Delivered by a Iontophoresis Device
Lead sponsor Asociación para Evitar la Ceguera en México, Other
Status Withdrawn
Phase Phase 1/Phase 2
Study type Interventional
Conditions Uveitis
Intervention type Device
Interventions Iontophoresis second generation Eyegate II device
Enrollment 0
Start date Sep 1, 2007
Primary completion Sep 1, 2007
Completion Sep 1, 2009
First posted Jul 11, 2007
Last update posted May 30, 2024
Countries Mexico

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies